Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography
2013
Introduction
Positron emission tomography (PET) imaging with F-18 fluorodeoxyglucose (FDG) has been used to identify characteristic patterns of regional glucose metabolism in patients with idiopathic Parkinson's disease (IPD) and the atypical parkinsonian syndromes of progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal syndrome (CBS). We undertook this study to assess the utility of fluorodeoxyglucose-PET in the differential diagnosis of individual patients with clinical parkinsonism. “Visual” and “computer-supported” reading of the fluorodeoxyglucose-PET scans were used for image interpretation and compared with each other.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
52
Citations
NaN
KQI